Chemotherapy Tolerance and Oncologic Outcomes in Patients With Colorectal Cancer With and Without Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) is a risk factor for colorectal cancer (CRC). We evaluated chemotherapy tolerance and oncologic outcomes from the medical records of patients with CRC with and without IBD. In this series, patients with CRC with IBD experienced more treatment alterations than those w...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Colorectal Cancer
Autores principales: Axelrad, Jordan, Kriplani, Anuja, Ozbek, Umut, Harpaz, Noam, Colombel, Jean-Frederic, Itzkowitz, Steven, Holcombe, Randall F., Ang, Celina
Formato: Artigo
Lenguaje:Inglês
Publicado: 2016
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6009836/
https://ncbi.nlm.nih.gov/pubmed/27742264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clcc.2016.09.005
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares